The influence of mass of [11C]-laniquidar and [11C]-N-desmethylloperamide on P-glycoprotein blockage at the blood-brain barrier
- Author
- Lieselotte Moerman (UGent) , Caroline Dumolyn (UGent) , Paul Boon (UGent) and Filip De Vos (UGent)
- Organization
- Keywords
- P-glycoprotein, 11C-laniquidar, 11C-desmethylloperamide, PET tracers, Multidrug resistance, Mdrla (-/-) mice, In vivo experiments, P-gp inhibitors, P-gp substrates, MULTIDRUG-RESISTANCE, TRANSPORTERS, INHIBITORS, EFFLUX, DRUGS, RADIOSYNTHESIS, RADIOLIGAND, MICE, PET
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 315.82 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-1981276
- MLA
- Moerman, Lieselotte, et al. “The Influence of Mass of [11C]-Laniquidar and [11C]-N-Desmethylloperamide on P-Glycoprotein Blockage at the Blood-Brain Barrier.” NUCLEAR MEDICINE AND BIOLOGY, vol. 39, no. 1, 2012, pp. 121–25, doi:10.1016/j.nucmedbio.2011.06.009.
- APA
- Moerman, L., Dumolyn, C., Boon, P., & De Vos, F. (2012). The influence of mass of [11C]-laniquidar and [11C]-N-desmethylloperamide on P-glycoprotein blockage at the blood-brain barrier. NUCLEAR MEDICINE AND BIOLOGY, 39(1), 121–125. https://doi.org/10.1016/j.nucmedbio.2011.06.009
- Chicago author-date
- Moerman, Lieselotte, Caroline Dumolyn, Paul Boon, and Filip De Vos. 2012. “The Influence of Mass of [11C]-Laniquidar and [11C]-N-Desmethylloperamide on P-Glycoprotein Blockage at the Blood-Brain Barrier.” NUCLEAR MEDICINE AND BIOLOGY 39 (1): 121–25. https://doi.org/10.1016/j.nucmedbio.2011.06.009.
- Chicago author-date (all authors)
- Moerman, Lieselotte, Caroline Dumolyn, Paul Boon, and Filip De Vos. 2012. “The Influence of Mass of [11C]-Laniquidar and [11C]-N-Desmethylloperamide on P-Glycoprotein Blockage at the Blood-Brain Barrier.” NUCLEAR MEDICINE AND BIOLOGY 39 (1): 121–125. doi:10.1016/j.nucmedbio.2011.06.009.
- Vancouver
- 1.Moerman L, Dumolyn C, Boon P, De Vos F. The influence of mass of [11C]-laniquidar and [11C]-N-desmethylloperamide on P-glycoprotein blockage at the blood-brain barrier. NUCLEAR MEDICINE AND BIOLOGY. 2012;39(1):121–5.
- IEEE
- [1]L. Moerman, C. Dumolyn, P. Boon, and F. De Vos, “The influence of mass of [11C]-laniquidar and [11C]-N-desmethylloperamide on P-glycoprotein blockage at the blood-brain barrier,” NUCLEAR MEDICINE AND BIOLOGY, vol. 39, no. 1, pp. 121–125, 2012.
@article{1981276, author = {{Moerman, Lieselotte and Dumolyn, Caroline and Boon, Paul and De Vos, Filip}}, issn = {{0969-8051}}, journal = {{NUCLEAR MEDICINE AND BIOLOGY}}, keywords = {{P-glycoprotein,11C-laniquidar,11C-desmethylloperamide,PET tracers,Multidrug resistance,Mdrla (-/-) mice,In vivo experiments,P-gp inhibitors,P-gp substrates,MULTIDRUG-RESISTANCE,TRANSPORTERS,INHIBITORS,EFFLUX,DRUGS,RADIOSYNTHESIS,RADIOLIGAND,MICE,PET}}, language = {{eng}}, number = {{1}}, pages = {{121--125}}, title = {{The influence of mass of [11C]-laniquidar and [11C]-N-desmethylloperamide on P-glycoprotein blockage at the blood-brain barrier}}, url = {{http://doi.org/10.1016/j.nucmedbio.2011.06.009}}, volume = {{39}}, year = {{2012}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: